LOS ANGELES, Oct. 30, 2014 /PRNewswire/ -- Medbox,
Inc. (OTCQB: MDBX) (www.medbox.com), a leading dispensary
infrastructure/licensing specialist, patented technology provider,
and partner to the cannabis industry, is proud to announce the
addition of Tim Morrissey to lead
Medbox's wholly owned subsidiary, Vaporfection International, Inc.,
as Director and Vice-President.
Mr. Morrissey is the founder and Chief Executive Officer of Head
Choice Inc., which is involved in many facets of the vaporization
industry including consultation, manufacturing, sales and
distribution. Its brands include the Da Buddha vaporizer, the
Silver Surfer vaporizer, the Journey 2 and Journey 3 and most
recently the Pax by Ploom. Mr. Morrissey's involvement with the Pax
ranged from overseeing early stage design concepts, beta testing
and marketing plans, to aiding in elements of overseas
manufacturing, the original launch, and sales into more than 5,000
stores nationwide. Mr. Morrissey speaks both Cantonese, and
Mandarin Chinese and owns his own factory in Guangzhou China. Mr. Morrissey has also
successfully built a hemp and recycled polyester bag company,
Dragons Breath LLC, whose products are among the most recognized in
the smoking accessories industry. Some of these successes have come
from working with vaporizer companies to produce their own
co-branded carrying cases for many of the vaporizers in the market
today.
"I'm pleased to have someone with Tim's background and skills
leading Vaporfection International, especially as we roll out our
exciting new portable vaporizer, the miVape," commented
Guy Marsala, CEO at Medbox, Inc.
"This is yet another key development in the maturation process of
Medbox's leadership team and business model."
Mr. Morrissey stated, "In 2012 and 2013 my company was selected
to be the exclusive distributor of the Pax vaporizer and had the
most successful launch of a product into the specialty smoking
industry. I am now setting my sights on the Vaporfection
award-winning line of products that feature patented glass-on-glass
heating and a host of features patients and consumers will
undoubtedly enjoy. I am ecstatic that Medbox has chosen me to lead
this brand and I will do my part to bring value to the company and
its shareholders."
Management commented that the new miVape portable vaporizer that
is being launched in December of this year is anchored by four new
design and utility patents issued earlier this year (D708,727 S;
8,739,786 B2; US 8,739,787 B2; and US 8,739,788 B2).
About Medbox,
Inc:
Medbox (http://www.medbox.com) is the leading dispensary
infrastructure and licensing specialist, patented technology
provider, and partner to the cannabis industry. Headquartered in
Los Angeles, CA, Medbox, through
its wholly owned subsidiary, Medicine Dispensing Systems, offers
its patented systems, software and consulting services to
pharmacies, alternative medicine dispensaries and local governments
in the U.S. In addition, through its wholly owned subsidiary,
Vaporfection International, Inc. (www.vaporfection.com), the
company offers an industry award winning line of medical vaporizer
products. Medbox, through its newly established subsidiaries, is
also developing ancillary services tailored to the alternative
medicine industry, including: real estate acquisitions and
subsequent lease programs to alternative medicine dispensaries and
cultivation centers, and alternative medicine dispensary and
cultivation management services.
Forward-Looking Statements:
Statements in this press release constitute forward-looking
statements within the meaning of federal securities laws. Such
statements are based on our current beliefs and expectations and
are inherently subject to significant business, economic and
competitive uncertainties and contingencies, many of which are
beyond our control. In addition, such forward-looking statements
are subject to assumptions with respect to future business
strategies and decisions that are subject to change. Potential
risks and uncertainties include, but are not limited to, technical
advances in the industry as well as political and economic
conditions present within the industry. We do not take any
obligation to update any forward-looking statement to reflect
events or developments after a forward-looking statement was
made.
Contacts:
|
|
Investor
Relations
|
Media
Relations
|
Stephen
Hart
|
Jackie Herskovitz
Russell
|
Hayden IR
|
Teak Media +
Communications
|
917-658-7878
|
O:
617-269-7171
|
hart@haydenir.com
|
jackie@teakmedia.com
|
|
@TeakMedia
|
Medbox:
For more information on Medbox, please call (800) 762-1452 or visit
www.medbox.com.
SOURCE Medbox, Inc.